Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Bioimplants Companies

ID: MRFR/MED/5431-HCR
85 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Bioimplants, also known as biomedical implants, are devices or tissues that are placed inside or on the surface of the body. These implants are used to replace or support damaged biological structures, improve bodily functions, or monitor and control various physiological processes.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Bioimplants Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.13%
2024 Market Size$ 59.34 Billion
2025 Market Size$ 62.38 Billion
2035 Market Size$ 102.87 Billion
Key Players
Medtronic
Stryker
Johnson & Johnson
Zimmer Biomet
Boston Scientific
Abbott Laboratories
Opportunities
  • Expanding Applications of Bioimplants
  • Technological Innovations in Bioimplants
  • Increasing Prevalence of Chronic Diseases

Top Industry Leaders in the Bioimplants Market

Bio implants Market
 

Latest Bio implants Companies Updates:

Stryker Corporation: Received FDA approval for the MakoTotal Hip System in June 2023, featuring robotic-assisted technology for enhanced precision and accuracy in hip replacement surgery.

Zimmer Biomet Holdings, Inc.: Launched the T3 pro Tampered Implant & Encode Emergence Healing Abutment in the U.S. in June 2023, designed for improved osseointegration and dental implant stability.

Johnson & Johnson (Depuy): Partnered with a research institute in January 2024 to develop AI-powered tools for optimizing design and manufacturing of personalized knee implants.

Medtronic plc: Announced the expansion of its regenerative medicine program in February 2024, aiming to invest in and develop innovative tissue engineering solutions for cartilage and bone regeneration.

Exacel, Inc.: Received CE Mark approval for their InFuse® Bioabsorbable Bone Graft Substitute in December 2023, offering a natural and dissolvable alternative to traditional bone graft materials.

List of Bio implants Key companies in the market:

  • Abbott
  • Boston Scientific Corporation
  • Dentsply Sirona
  • Johnson & Johnson Services, Inc.
  • Invibio Ltd.
  • Integra LifeSciences
  • Medtronic
  • Smith & Nephew plc
  • Stryker
  • Wright Medical Group N.V.